Home Propanc Biopharma

Propanc Biopharma

In operation
IPO
Clinical-Stage Cancer Therapeutics Developer

Basic Information

Propanc Biopharma is a clinical-stage biopharmaceutical company dedicated to developing new cancer treatments for patients with pancreatic, ovarian, and colorectal cancers. In collaboration with our scientific and oncology advisors, we have developed a rational combination of anticancer compounds that work together through multiple mechanisms to control or prevent tumor recurrence and metastasis within the body.
Propanc Biopharma, Inc.
Victoria,Australia
15~50 people
November 23, 2010
--